Buys
Open market- Shares
- +8,000
- Avg price
- $1.21
- Total value
- +$9,705
Albert Luderer - Interim Chief Executive, Director at Bionano Genomics, Inc.
Issuer-level insider activity
- Role
- Interim Chief Executive, Director
- Issuer ticker
- BNGO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Albert Luderer in Bionano Genomics, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +8,000
- Share %
- 100%
- Total value
- +$9,705
Reported holdings for Albert Luderer in Bionano Genomics, Inc.
Form 4 holding
Interim Chief Executive, Director
Bionano Genomics, Inc.
- Security class
- Common Stock
- Shares / value
- 8,000
- Estimated value
- $9,689
- Report date
- 04 Sep 2026
- Price
- $1.21
- Ownership
- Traditional IRA
Form 4 holding
Interim Chief Executive, Director
Bionano Genomics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 2,775
- Estimated value
- Report date
- 11 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Albert Luderer in Bionano Genomics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.